Raymond James analyst C. Gregory Peters keeps an Outperform rating on Health Insurance Innovations shares, but said he fears the stock “appears to be broken” and could see additional weakness as broker-dealers have to short more shares to keep their books neutral if the stock continues to slide. While he does not believe that legislation introduced in the House of Representatives to prevent the enforcement of a recent regulation aimed at increasing the number of people with short-term limited duration insurance will see action in the Senate, Peters acknowledges the overhang that the bill has been on Health Insurance Innovations shares.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.